share_log

Analyst's Squeeze Play: Can Beyond Meat, Aurora Cannabis Juice The Shorted Stocks?

Analyst's Squeeze Play: Can Beyond Meat, Aurora Cannabis Juice The Shorted Stocks?

分析師的擠壓策略:can Beyond Meat和極光大麻漲停股票?
Benzinga ·  06/18 12:55

A short squeeze forces investors betting on a stock's decline (short sellers) to buy back shares at a higher price to avoid losses, triggering a price surge. Analyst Faizan Farooque sees this potential in Aurora Cannabis (NASDAQ:ACB) and Beyond Meat (NASDAQ:BYND) due to their recent actions and current market conditions.

空頭持倉強迫押注在股票下跌的投資者(賣空者)以更高的價格買回股票以避免損失,從而引發價格暴漲。分析師Faizan Farooque認爲極光大麻(納斯達克:ACB)和Beyond Meat(納斯達克:BYND)在其近期行動和當前市場情況下有這種潛力。

Beyond Meat

Beyond Meat

Beyond Meat is facing a challenging environment with persistent inflation, competition from Impossible Foods and a notable drop in plant-based meat revenues.

Beyond Meat面臨着持續通脹、與Impossible Foods的競爭以及人造肉收入的顯着下降等嚴峻環境。該公司的淨銷售額下降了18%,導致淨虧損1.551億美元。儘管存在這些挫折,Beyond Meat預計2024年的銷售額爲3.15億美元至3.45億美元。

The company's net sales fell 18%, resulting in a net loss of $155.1 million. Despite these setbacks, Beyond Meat projects sales of $315 million to $345 million for 2024.

爲了應對這些挑戰,Beyond Meat推出了Beyond IV,這是一條新產品線,比傳統牛肉含有75%的飽和脂肪和20%的鹽分,每份含有21克的蛋白質。根據Farooque的說法,該公司正在專注於庫存優化,取消了Beyond Jerky,以優先考慮更具利潤的Beyond IV系列。此外,BYND正在削減2024年的預算7,000萬美元,作爲其SKU合理化進程的一部分。目前,該股票的空頭持倉率接近40%,去年下跌了近50%。

To counter these challenges, Beyond Meat introduced Beyond IV, a new product line boasting 75% less saturated fat and 20% less salt than traditional beef, and containing 21 grams of protein per serving.

爲了應對這些挑戰,Beyond Meat推出了Beyond IV,這是一條新產品線,比傳統牛肉含有75%的飽和脂肪和20%的鹽分,每份含有21克的蛋白質。根據Farooque的說法,該公司正在專注於庫存優化,取消了Beyond Jerky,以優先考慮更具利潤的Beyond IV系列。此外,BYND正在削減2024年的預算7,000萬美元,作爲其SKU合理化進程的一部分。目前,該股票的空頭持倉率接近40%,去年下跌了近50%。

According to Farooque, the company is focusing on inventory optimization, discontinuing Beyond Jerky to prioritize the more profitable Beyond IV line. Additionally, BYND is cutting its 2024 budget by $70 million as part of its SKU rationalization process. Currently, the stock has nearly 40% short interest and has dropped almost 50% in the past year.

根據Farooque的說法,該公司正在專注於庫存優化,取消了Beyond Jerky,以優先考慮更具利潤的Beyond IV系列。此外,BYND正在削減2024年的預算7,000萬美元,作爲其SKU合理化進程的一部分。目前,該股票的空頭持倉率接近40%,去年下跌了近50%。

Aurora Cannabis

極光大麻

Aurora Cannabis continues to be a notable name in the short-squeeze arena, largely due to marijuana's federal illegality in the U.S. However, Farooque noted Aurora reported its fifth consecutive quarter of positive adjusted EBITDA, with quarterly net sales up 5% to 64.4 million CAD.

極光大麻繼續成爲空頭持倉競技場上值得關注的名字,這在很大程度上是由於大麻在美國的聯邦非法性引起的。然而,Farooque指出極光大麻報告了其第五個連續季度的正向調整EBITDA,季度淨銷售額增長了5%至6,440萬加元。

The company is also reducing its debt, recently repurchasing 23.1 million CAD in convertible debentures.

該公司還在減少其債務,最近回購了2,310萬加元的可轉換債券。

Despite these positives, consumer cannabis revenue fell by 21% year-over-year, and adjusted SG&A expenses remained high, according to Farooque.

儘管有這些積極因素,Farooque指出,消費者大麻收入同比下降了21%,調整後的銷售和行政費用仍然很高。

He explained a reverse stock split in February 2024 aimed to stabilize the stock price, but ACB is still trading at $5.90, well below its 52-week high of $11.5.

他解釋說,2024年2月的反向股票分割旨在穩定股價,但ACB仍然以5.90美元的價格交易,遠低於其52周高點11.5美元。加拿大市場的緩慢增長進一步複雜化了Aurora的位置,使其成爲一種迫切需要被壓縮的股票。

The Canadian market's slow growth further complicates Aurora's position, keeping it among the stocks primed for a squeeze.

加拿大市場的緩慢增長進一步複雜化了Aurora的位置,使其成爲一種迫切需要被壓縮的股票。

Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly for top executives, investors, and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

大麻重新分類似乎已經指日可待。想了解這對該行業未來的意義?那就直接向19屆Benzinga大麻資本大會上的高管、投資者和政策制定者聽取。該活動將於10月8日至9日在芝加哥舉行。立即購票,避免價格飆漲,請關注此鏈接.

Photo by Tangerine Newt on Unsplash.

由Tangerine Newt提供的照片,來自Unsplash。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論